By Randy Dotinga, HealthDay More U.S. physicians are sparing their low-risk prostate cancer patients from surgery, radiation and hormone therapy in favor of monitoring their patients over ...
Read More »Watch-and-Wait Strategy May Be Riskier for Prostate Cancer
(HealthDay News) — Choosing active surveillance over treatment for prostate cancer may decrease the odds of survival in men with intermediate-risk cancer, a new study ...
Read More »